Clinical Trial Update: TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma [NA]

View source ↗

Summary

The update indicates that a trial evaluating the TheraBionic P1 Device for advanced/recurrent hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TheraBionic P1 Device

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Hepatocellular Carcinoma Recurrent | NA | Status: RECRUITING